Healthcare providers and health insurance

22. 1. 2025 · Significant Matters

HAVEL & PARTNERS is advising the emeis/SeneCura Group on selling its Czech nursing-home and Alzheimer-centre operations, around 2,200 beds across 17 facilities, to Penta Hospitals, with closing expected in the first half…

9. 5. 2024 · Publications and newsletters

The Czech Ministry of Health has proposed an amendment to the Public Health Insurance Act, effective 1 January 2026, covering price and reimbursement rules for medicines and medical devices, preventive care incentives,…

20. 9. 2021 · Publications and newsletters

The Chamber of Deputies approved a wide-ranging amendment to the Public Health Insurance Act overhauling reimbursement of highly innovative medicinal products and orphan drugs, introducing a definition of patient organisation, and raising…

1. 9. 2020 · Significant Matters

HAVEL & PARTNERS, led by partner Vaclav Audes, advised development capital fund Genesis Capital Growth on acquiring a 100% stake in Home Care Promedica, a Prague-based provider of specialised home healthcare and…

11. 2. 2019 · Articles and Interviews

From 1 January 2019, an amendment to the Czech General Health Insurance Act introduced a notification-based reimbursement system for consumer medical devices such as glucose meters and hearing aids, replacing the scheme…

1. 1. 2019 · Publications and newsletters

HAVEL & PARTNERS' January 2019 Pharma Flash reports that Act No. 282/2018 Coll., effective 1 January 2019, introduced a notification-based reimbursement system for consumer medical devices, replacing the scheme struck down by…

1. 12. 2018 · Publications and newsletters

The December 2018 issue of HAVEL & PARTNERS' Pharma Flash newsletter covers a CJEU ruling that reimbursing a medicinal product for off-label use does not breach EU law.

1. 5. 2018 · Publications and newsletters

The May 2018 issue of Pharma Flash newsletter covers recent regulatory updates on the reimbursement of medical devices in the Czech Republic.